Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1491 of 5804
-
New shot cuts dangerous fat levels in blood
Disease control CompletedThe purpose of this study is to evaluate the efficacy of olezarsen as compared to placebo on the percent change in fasting triglycerides (TG) from baseline.
Phase: PHASE3 • Sponsor: Ionis Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
New combo inhaler shows promise for better asthma control in large trial
Disease control CompletedCompare the superiority of CHF 1535 versus CHF 718 in subjects with asthma who are on medium or high dose inhaled corticosteroids.
Phase: PHASE3 • Sponsor: Chiesi Farmaceutici S.p.A. • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
New hope for advanced breast cancer: drug combo trial opens
Disease control Recruiting nowThis is a Phase 1b open-label, 2-part study in 3 treatment groups. The 3 treatment groups are as follows: Treatment Group 1: Palazestrant (OP-1250) in combination with ribociclib (KISQALI®, Novartis Pharmaceuticals Corporation). Treatment Group 2: Palazestrant (OP-1250) in comb…
Phase: PHASE1 • Sponsor: Olema Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
New cocktail of four drugs takes on Hard-to-Treat myeloma
Disease control OngoingThe primary purpose is to determine the safety and tolerability of belantamab mafodotin in combination with nirogacestat, pomalidomide, and dexamethasone and to establish the recommended Phase 2 dose for combination treatment to explore in the cohort expansion (CE) phase in parti…
Phase: PHASE1, PHASE2 • Sponsor: GlaxoSmithKline • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
New imaging agent could reveal prostate cancer treatment success in real time
Diagnosis Recruiting nowBackground: Identifying medium- and high-risk prostate cancer early may allow for treatments to work. But identification can be hard. Researchers want to see if a radiotracer used during PET scans can help. Objective: To test how an imaging agent called 18F-DCFPyL detects resp…
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Diagnosis
Last updated Jul 18, 2026 00:00 UTC
-
Virtual reality boosts stroke recovery? new study investigates
Knowledge-focused Recruiting nowStroke is the leading cause of acquired disability in adults. Neurorehabilitation aims to recover the affected function by stimulating neuroplasticity. Immersive virtual reality (IVR) has shown that it can be effective but the evidence is still weak. Similarly, few studies have a…
Phase: NA • Sponsor: Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:38 UTC
-
Radioactive drug lutathera tested in teens with rare cancers
Disease control OngoingThis is a multicenter, open-label, single-arm study to evaluate the safety and dosimetry of Lutathera in adolescent patients 12 to \<18 years old with somatostatin receptor positive GEP-NETs and PPGLs. The study will enroll at least 8 patients in the GEP-NET cohort and as many ad…
Phase: PHASE2 • Sponsor: Advanced Accelerator Applications • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
New combo strategy aims to catch and remove leftover cancer after radiation
Disease control OngoingThe goal of this phase I clinical trial is to learn whether a multimodal follow-up evaluation combined with endoscopic selective neck dissection (ESND) is safe and feasible in patients with newly diagnosed N3 nasopharyngeal carcinoma. The main questions it aims to answer are: *…
Phase: PHASE1 • Sponsor: Guiquan Zhu • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
New hope for kids with psoriatic arthritis: drug combo under trial
Disease control OngoingThe purpose of this study is to evaluate the pharmacokinetics (PK), efficacy, safety and immunogenicity of ustekinumab and guselkumab in active juvenile psoriatic arthritis (jPsA).
Phase: PHASE3 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
Can a common drug stop brain bleeds? major trial launches
Disease control Recruiting nowThis multicenter, pragmatic randomized, open-label clinical trial aims to assess whether Tranexamic Acid improves outcomes in adult patients with spontaneous intracerebral haemorrhage. The participants presenting within 4.5 hours of the onset of symptoms of stroke with intracere…
Phase: PHASE4 • Sponsor: Christian Medical College and Hospital, Ludhiana, India • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
New collagen patch aims to speed up shoulder tear recovery
Disease control Recruiting nowThe purpose of the study is to assess whether the REGENETEN™ Bioinductive Implant allows patients to get back to their everyday activities quicker than if the tendon is repaired by the standard repair technique 'Completion and Repair' for surgically treating partial-thickness rot…
Phase: NA • Sponsor: Smith & Nephew, Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
New drug shows promise for rare ovarian cancer in early trial
Disease control CompletedThis phase 2 clinical trial will study the effectiveness of nirogacestat in ovarian granulosa cell tumors (OvGCTs). Nirogacestat is a gamma secretase inhibitor (GSI) which is hypothesized to decrease the growth and activity of ovarian granulosa tumors.
Phase: PHASE2 • Sponsor: SpringWorks Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
Can talk therapy rewire the Gut-Brain connection in HIV?
Knowledge-focused Recruiting nowThe purpose of this randomized controlled trial is to understand how a cognitive-behavioral treatment (a form of psychological treatment) for depression changes the gut microbiome (micro-organisms that regulate the health of the gut), immune system, and the brain functioning in p…
Phase: NA • Sponsor: Florida International University • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:03 UTC
-
Weekly shot may help diabetics use less insulin and lose weight
Disease control CompletedThis study compares semaglutide, together with a lower dose of insulin glargine, to a higher dose of insulin glargine in participants with type 2 diabetes. The study looks at how well the study medicines control blood glucose levels. Participants will either get semaglutide toget…
Phase: PHASE3 • Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
New antibody combo shows promise for Hard-to-Treat cancers
Disease control OngoingA Phase I/II, Open-Label, Dose-Escalation and Dose-Expansion Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetic Profile and Preliminary Efficacy of LM-108, an Anti-CCR8 Monoclonal Antibody, as Monotherapy or in Combination with Antitumor Therapies in Patients wi…
Phase: PHASE1, PHASE2 • Sponsor: LaNova Medicines Limited • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
Freezing out AFib: new device tested in Real-World study
Disease control CompletedThis is a post-market study collecting real-world clinical data on safety, effectiveness and procedural success of Boston Scientific Cardiac Cryoablation System (POLARx™ System)
Sponsor: Boston Scientific Corporation • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
New hope for HER2 cancers: first human trial launches
Disease control Recruiting nowThis first-in-human study will be counducted to evaluate the safety, tolerability, pharmacokinetics (PK) and anti-tumor activity of YH32367 in Patients with HER2-Positive Locally Advanced or Metastatic Solid Tumors.
Phase: PHASE1, PHASE2 • Sponsor: Yuhan Corporation • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
Brain training may quiet voices in schizophrenia
Symptom relief Recruiting nowThe INTRUDE trial aims at assessing the efficacy of an fMRI-based neurofeedback procedure on drug-resistant auditory hallucinations. Hallucinations are complex and transient mental states associated with subtle and brain-wide patterns of activity for which we were recently able t…
Phase: NA • Sponsor: University Hospital, Lille • Aim: Symptom relief
Last updated Jun 27, 2026 12:34 UTC
-
New vaccine trial aims to boost Chemo's power against tough breast cancers
Disease control Recruiting nowThe purpose of the study is to find out if an investigational vaccine called Dendritic Cell (DC) vaccine given together with standard of care chemotherapy drugs can help people with Triple Negative and HR low positive breast cancer.
Phase: PHASE1 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
New triple therapy aims to control advanced breast cancer with fewer side effects
Disease control Recruiting nowThis is a Phase 1b/2, open-label, parallel-arms pilot study in men and post-menopausal women with hormone receptor positive (HR+), HER2- advanced or metastatic breast cancer with an alteration in the PI3K pathway, including a mutation of the PIK3CA gene, PTEN loss, or AKT1 mutati…
Phase: PHASE1, PHASE2 • Sponsor: SynDevRx, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC